Multiple Myeloma Real-World Data on Immunotherapy for Relapsed/Refractory Multiple Myeloma clinical topic updates By Irene M. Ghobrial, MD
Multiple Myeloma Supportive Care for Patients With Multiple Myeloma Who Are Undergoing Treatment With Chimeric Antigen Receptor T Cells or Bispecific Antibodies patient care perspectives By Saad Z. Usmani, MBBS, MD, MBA, FACP, FRCP, FASCO
Multiple Myeloma The Role of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma expert roundtables By Kenneth C. Anderson, MD; Carol Ann Huff, MD; Shaji K. Kumar, MD
Multiple Myeloma Off-Study and On-Study Regimens for Relapsed Multiple Myeloma After 4 Prior Lines of Therapy patient care perspectives By Kenneth C. Anderson, MD